Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients With Spinal Muscular Atrophy

NCT02644668 is registered in ClinicalTrials.gov with Cytokinetics as lead sponsor.

NCT NCT02644668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients With Spinal Muscular Atrophy
Lead sponsor
Cytokinetics
Phase
Phase 2
Overall status
Completed
Start date
January 14, 2016
Completion date
May 31, 2018
Enrollment
70 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

spinal muscular atrophy